Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Kate Watkins, Professor of Cognitive Neuroscience in the Department of Experimental Psychology is the inaugural co-Editor-in-Chief of a new open access journal: the Neurobiology of Language.

Neurobiology of Language now accepting submissions

Neurobiology of Language is a new open access, peer reviewed journal, which will publish interdisciplinary articles on the neurobiological basis of speech and language. It has been sponsored by the Society of Neurobiology and MIT Press. The Department of Experimental Psychology’s Prof Kate E Watkins, along with Prof Steven L Small of the University of Texas at Dallas are serving as the opening Editors-in-Chief.

Understanding the basis of speech and language presents fascinating new opportunities in cognitive sciences, and this new journal will work on expanding these frontiers. By serving as an outlet for the exchange of important findings, both positive and negative. The journal will be operating a system of “registered reports”, or submissions consisting of only the introduction and detailed methods prior to data collection will be reviewed and considered, thereby leading to more robust research findings across the field of study. As well as primarily publishing research articles, this new journal will also be publishing reviews and perspectives, and all content will be freely available to researchers across the globe.

Read more (Department of Experimental Psychology website)

Similar stories

Long COVID: vaccination could reduce symptoms, new research suggests

While evidence suggests that people who are vaccinated before they get COVID are less likely to develop long COVID than unvaccinated people, the effectiveness of vaccination on existing long COVID has been less clear.

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.